12/5
08:07 am
okur
Rating for OKUR
Low
Report
Rating for OKUR
12/5
08:06 am
okur
OnKure Therapeutics (NASDAQ: OKUR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $33.00 price target on the stock.
Low
Report
OnKure Therapeutics (NASDAQ: OKUR) is now covered by analysts at Leerink Partners. They set an "outperform" rating and a $33.00 price target on the stock.
12/5
06:23 am
okur
OnKure Therapeutics initiated with an Outperform at Leerink
Low
Report
OnKure Therapeutics initiated with an Outperform at Leerink
11/8
02:32 pm
okur
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
10/17
10:38 am
okur
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
Low
Report
OnKure Therapeutics (NASDAQ: OKUR) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $40.00 price target on the stock.
10/10
08:33 am
okur
OnKure Therapeutics (NASDAQ: OKUR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $35.00 price target on the stock.
Low
Report
OnKure Therapeutics (NASDAQ: OKUR) is now covered by analysts at Oppenheimer Holdings Inc.. They set an "outperform" rating and a $35.00 price target on the stock.
10/10
08:04 am
okur
Rating for OKUR
Low
Report
Rating for OKUR
10/10
08:04 am
okur
Rating for OKUR
Low
Report
Rating for OKUR